Clinical research

Dermatology clinical trials. Eczema and psoriasis studies in Downtown LA and Brentwood

Metropolis participates in clinical research when appropriate opportunities are available. Research studies evaluate treatments or technologies that may still be in development and follow specific requirements for eligibility, consent, monitoring, and follow-up.

Research team: (424) 393-0005 or trials@metropolisderm.com.

Studies at Metropolis.

Enrollment status checked on ClinicalTrials.gov on November 7, 2026. Studies open and close often; the research team confirms what is open when they call you.

EnrollingBrentwood

Moderate to severe eczema (atopic dermatitis)

A study of camoteskimab, an investigational medicine given as an injection under the skin, in adults whose eczema has not been controlled by creams and ointments, or for whom those treatments are not advisable.

Who may qualify
Adults 18 to 65 who have had eczema for at least a year, covering at least 10% of the body, with itch that rates at least 4 out of 10. Other requirements apply; the research team reviews the full list with you.
How it works
For the first 24 weeks, participants are assigned by chance to one of three doses or a placebo, an injection with no active medicine, and neither you nor the study team knows which. After that, everyone receives camoteskimab.
Study stage
Phase 2b, sponsored by Apollo Therapeutics.
Full listing on ClinicalTrials.gov, NCT07599813
EnrollingDowntown LA

Moderate to severe plaque psoriasis with overweight or obesity

A study of adding tirzepatide, an injection under the skin, for adults who recently started ixekizumab (Taltz) for psoriasis. Everyone in this study receives tirzepatide; there is no placebo.

Who may qualify
Adults 18 and older who started ixekizumab about three months ago (between two and four months), with a BMI of 30 or more, or a BMI of 27 to 30 with a weight-related condition such as high blood pressure, high cholesterol, type 2 diabetes, sleep apnea, or heart disease.
Who may not
Anyone who has taken tirzepatide or another GLP-1 medicine, or who has a personal or family history of medullary thyroid cancer. The research team reviews the full list with you.
Length
Up to 12 months. Phase 4, sponsored by Eli Lilly and Company.
Full listing on ClinicalTrials.gov, NCT06857942
Not yet open hereDowntown LA

Moderate to severe eczema (atopic dermatitis), tablet

A study of PF-08049820, an investigational tablet taken by mouth once a day for 12 weeks, in adults without a suitable prescribed medicine for their eczema.

Who may qualify
Adults 18 to 64 who have had eczema for at least six months, covering 10% to 60% of the body, with a BMI of 18 to 38. Other requirements apply; the research team reviews the full list with you.
How it works
Participants are assigned by chance to one of three doses or a placebo tablet. Visits on day 1 and weeks 1, 2, 4, 6, 8, and 12, then a follow-up at week 16, with skin checks and blood and urine tests.
Study stage
Phase 2, sponsored by Pfizer. Our Downtown LA site is listed as not yet recruiting. Fill out the form and the research team will contact you if this study opens here.
Full listing on ClinicalTrials.gov, NCT07216027

Our trials keep updating. If none of these fits you today, the form puts you on our list, and the research team will contact you when a study opens that may.

How to join.

  1. Fill out the one-minute form. Tell us your condition and how to reach you.
  2. We call you. The research team checks whether a study may fit and books a screening visit.
  3. Screening visit. The study team goes through the consent form with you first. Once you agree, they examine your skin and confirm whether you qualify.

Before you join.

Participation is voluntary and is different from receiving established treatment during a standard medical visit.

  • You decide, and you can stop. You can leave a study at any time. Choosing not to join, or leaving, does not change the regular care you receive at Metropolis.
  • You see everything first. Before you agree, the study team explains the purpose, the visits, the possible risks and benefits, and your other treatment options, and answers your questions.
  • Results are not promised. A study medicine is being tested, so it may not help, and it may have side effects that are not yet known. In placebo-controlled studies, some participants receive no active medicine.
  • You are not charged for study visits or study medicine. What a study covers is set by the study and explained before you agree. Studies may also offer compensation for your time and travel.

Questions.

Does joining a clinical trial cost anything?

You are not charged for study visits or study medicine. Each study sets what it covers, and the research team explains it before you agree.

Are clinical trial participants paid?

Studies may offer compensation for your time and travel. The amount differs by study, and the research team tells you the amount before you agree to take part.

Will I get a placebo?

It depends on the study. In the two eczema studies above, some participants receive a placebo, chosen by chance. In the psoriasis study, everyone receives the study medicine.

Do I need to stop my current treatment?

Each study has its own rules about other medicines, and some ask that you stay on one. The psoriasis study, for example, requires that you continue ixekizumab. Others ask you to pause certain medicines for a set time before you start. Do not stop a prescribed medicine on your own; the research team and your dermatologist decide this with you.

What if I do not qualify?

Our dermatologists treat eczema and psoriasis outside of studies. For psoriasis, options range from topical medication to phototherapy, oral medication, and biologic treatment. Medical dermatology at Metropolis, or read what patients say.

Where to go

Where studies take place.

Our studies run at two offices. The research team schedules every study visit.

The Downtown LA lobby with its walnut front desk
Original location and flagshipDowntown LA (DTLA)Suite 1050Our original location and flagship, serving a vibrant and diverse community where the Financial District, L.A. Live, and South Park meet.Psoriasis study enrolling; eczema tablet study not yet open here.888 S. Figueroa St, Los Angeles, CA 90017
(213) 319-3339
Dermatologist in Downtown LA
The Brentwood lobby with its gold ginkgo wall
BrentwoodSuite 900Comprehensive Westside dermatology with particular depth in injectables, advanced lasers, resurfacing, skin tightening, and hair and scalp conditions.Eczema injection study enrolling.11645 Wilshire Blvd, Los Angeles, CA 90025
(424) 243-7668
Dermatologist in Brentwood

Research team: (424) 393-0005 or trials@metropolisderm.com. Office lines are for regular appointments.

Book an appointment

Prefer a regular visit?

If you are uncertain which visit you need, we can help direct you before you book.

  • 4.7 on Google from 1,073 reviews
  • Insurance accepted for eligible medical care
  • Five California locations
Message us

Which office would you like to text?

Call an office

Which office?